vs
Apellis Pharmaceuticals, Inc.（APLS）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是OneStream, Inc.的1.2倍（$199.9M vs $163.7M），OneStream, Inc.净利率更高（0.6% vs -29.5%，领先30.1%），OneStream, Inc.同比增速更快（23.6% vs -5.9%），OneStream, Inc.自由现金流更多（$25.6M vs $-14.3M），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
APLS vs OS — 直观对比
营收规模更大
APLS
是对方的1.2倍
$163.7M
营收增速更快
OS
高出29.5%
-5.9%
净利率更高
OS
高出30.1%
-29.5%
自由现金流更多
OS
多$39.9M
$-14.3M
两年增速更快
OS
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $163.7M |
| 净利润 | $-59.0M | $999.0K |
| 毛利率 | — | 69.8% |
| 营业利润率 | -25.6% | -3.2% |
| 净利率 | -29.5% | 0.6% |
| 营收同比 | -5.9% | 23.6% |
| 净利润同比 | -62.2% | — |
| 每股收益（稀释后） | $-0.40 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSOS
| Q4 25 | $199.9M | $163.7M | ||
| Q3 25 | $458.6M | $154.3M | ||
| Q2 25 | $178.5M | $147.6M | ||
| Q1 25 | $166.8M | $136.3M | ||
| Q4 24 | $212.5M | $132.5M | ||
| Q3 24 | $196.8M | $129.1M | ||
| Q2 24 | $199.7M | $117.5M | ||
| Q1 24 | $172.3M | $110.3M |
净利润APLSOS
| Q4 25 | $-59.0M | $999.0K | ||
| Q3 25 | $215.7M | $-8.8M | ||
| Q2 25 | $-42.2M | $-18.4M | ||
| Q1 25 | $-92.2M | $-24.0M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $-171.9M | ||
| Q2 24 | $-37.7M | $-7.8M | ||
| Q1 24 | $-66.4M | $-5.0M |
毛利率APLSOS
| Q4 25 | — | 69.8% | ||
| Q3 25 | — | 68.1% | ||
| Q2 25 | — | 68.6% | ||
| Q1 25 | — | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | — | 69.1% |
营业利润率APLSOS
| Q4 25 | -25.6% | -3.2% | ||
| Q3 25 | 48.7% | -11.3% | ||
| Q2 25 | -18.6% | -21.8% | ||
| Q1 25 | -50.0% | -29.3% | ||
| Q4 24 | -12.3% | -35.8% | ||
| Q3 24 | -24.0% | -197.6% | ||
| Q2 24 | -14.7% | -9.8% | ||
| Q1 24 | -36.0% | -4.9% |
净利率APLSOS
| Q4 25 | -29.5% | 0.6% | ||
| Q3 25 | 47.0% | -5.7% | ||
| Q2 25 | -23.6% | -12.5% | ||
| Q1 25 | -55.3% | -17.6% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | -133.1% | ||
| Q2 24 | -18.9% | -6.7% | ||
| Q1 24 | -38.5% | -4.5% |
每股收益（稀释后）APLSOS
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.74 | — | ||
| Q4 24 | $-0.30 | — | ||
| Q3 24 | $-0.46 | $-1.06 | ||
| Q2 24 | $-0.30 | — | ||
| Q1 24 | $-0.54 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $693.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $504.7M |
| 总资产 | $1.1B | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSOS
| Q4 25 | $466.2M | $693.6M | ||
| Q3 25 | $479.2M | $653.9M | ||
| Q2 25 | $370.0M | $652.1M | ||
| Q1 25 | $358.4M | $593.9M | ||
| Q4 24 | $411.3M | $544.2M | ||
| Q3 24 | $396.9M | $495.5M | ||
| Q2 24 | $360.1M | $140.5M | ||
| Q1 24 | $325.9M | — |
总债务APLSOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSOS
| Q4 25 | $370.1M | $504.7M | ||
| Q3 25 | $401.2M | $472.1M | ||
| Q2 25 | $156.3M | $458.2M | ||
| Q1 25 | $164.2M | $412.9M | ||
| Q4 24 | $228.5M | $386.2M | ||
| Q3 24 | $237.1M | $458.2M | ||
| Q2 24 | $264.3M | $97.5M | ||
| Q1 24 | $266.7M | $102.5M |
总资产APLSOS
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.1B | $949.4M | ||
| Q2 25 | $821.4M | $910.5M | ||
| Q1 25 | $807.3M | $867.3M | ||
| Q4 24 | $885.1M | $823.2M | ||
| Q3 24 | $901.9M | $750.1M | ||
| Q2 24 | $904.5M | $379.7M | ||
| Q1 24 | $831.9M | — |
负债/权益比APLSOS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $25.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $25.6M |
| 自由现金流率自由现金流/营收 | -7.1% | 15.7% |
| 资本支出强度资本支出/营收 | 0.1% | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | $45.0M | $95.6M |
8季度趋势，按日历期对齐
经营现金流APLSOS
| Q4 25 | $-14.2M | $25.8M | ||
| Q3 25 | $108.5M | $5.0M | ||
| Q2 25 | $4.4M | $29.7M | ||
| Q1 25 | $-53.4M | $36.2M | ||
| Q4 24 | $19.4M | — | ||
| Q3 24 | $34.1M | $2.4M | ||
| Q2 24 | $-8.3M | $8.1M | ||
| Q1 24 | $-133.0M | $25.5M |
自由现金流APLSOS
| Q4 25 | $-14.3M | $25.6M | ||
| Q3 25 | $108.3M | $4.8M | ||
| Q2 25 | $4.4M | $29.4M | ||
| Q1 25 | $-53.4M | $35.8M | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | $-8.4M | $7.7M | ||
| Q1 24 | $-133.3M | $24.9M |
自由现金流率APLSOS
| Q4 25 | -7.1% | 15.7% | ||
| Q3 25 | 23.6% | 3.1% | ||
| Q2 25 | 2.5% | 19.9% | ||
| Q1 25 | -32.0% | 26.3% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | -4.2% | 6.6% | ||
| Q1 24 | -77.3% | 22.5% |
资本支出强度APLSOS
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | 0.2% | 0.6% |
现金转化率APLSOS
| Q4 25 | — | 25.79× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
